11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03914638 (ClinicalTrials.gov)	April 1, 2019	11/4/2019	Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis	Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis	Myasthenia Gravis	Drug: Salbutamol 4Mg Tablet;Drug: Placebo oral capsule	University of Aarhus	NULL	Recruiting	18 Years	N/A	All	30	Phase 2/Phase 3	Denmark
2	EUCTR2019-000895-40-DK (EUCTR)	28/03/2019	26/02/2019	Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia Gravis	Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia Gravis - BETA-MG	Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia gravi ...	Trade Name: Salbutamol WZF 4 mg INN or Proposed INN: Salbutamol Other descriptive name: SALBUTAMOL SULFA ...	Aarhus University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 3	Denmark

First Previous1Next Last